Caprini Score Calculator

Caprini Score Calculator for Hematology. Total scores are grouped into tiers that correspond to escalating VTE risk: roughly 0 (very low), 1 to 2 (low), 3 to 4 (moderate), and 5 or more (high), with many centers treating scores of 5+ and especially 7-8+ as warranting the most aggressive prophylaxis. In the Bahl validation cohort, observed 30-day VTE incidence rose from essentially 0% in the lowest categories to nearly 2% in the highest-risk group, and the CHEST framework attaches approximate absolute risks (about 0.5%, 1.5%, 3%, and 6%) to guide whether early ambulation alone, intermittent pneumatic compression, or heparin-based prophylaxis is appropriate. The action driven by the score is therefore concrete: a low tally often justifies mechanical measures or ambulation only, while a high tally shifts the balance toward pharmacologic prophylaxis absent a competing bleeding risk.

How this calculator works

The Caprini Score is a weighted additive risk-assessment model that sums points across roughly 40 individual venous thromboembolism (VTE) risk factors, each weighted 1 to 5 depending on its strength of association with postoperative thrombosis. Low-weight factors (1 point) include age 41 to 60, minor surgery, obesity, and oral contraceptive use; intermediate factors (2 to 3 points) include age over 60 or over 75, prior VTE, malignancy, central venous access, and family history of thrombosis; the highest-weight factors (5 points) include stroke, elective arthroplasty, hip/pelvis/leg fracture, and acute spinal cord injury. The total point sum maps the patient into a categorical risk tier that then drives a prophylaxis recommendation.

When to use this calculator

The score is designed for surgical inpatients — general, abdominal-pelvic, vascular, plastic/reconstructive, and other non-orthopedic populations — to stratify 30-day postoperative VTE risk and select mechanical versus pharmacologic prophylaxis. It is most useful at admission or in the preoperative clinic, where the tally directly informs whether to add low-molecular-weight heparin, use intermittent pneumatic compression alone, or extend prophylaxis after cancer surgery. It is not the preferred tool for major orthopedic (hip/knee arthroplasty, hip fracture) patients, who are already high-risk by procedure, nor for purely medical inpatients, where the Padua Prediction Score is the validated instrument.

Inputs used

  • Age
  • Surgery type
  • VTE history
  • Cancer
  • Mobility
  • Thrombophilia
  • Pregnancy or hormones
  • Comorbid conditions

Clinical interpretation

Total scores are grouped into tiers that correspond to escalating VTE risk: roughly 0 (very low), 1 to 2 (low), 3 to 4 (moderate), and 5 or more (high), with many centers treating scores of 5+ and especially 7-8+ as warranting the most aggressive prophylaxis. In the Bahl validation cohort, observed 30-day VTE incidence rose from essentially 0% in the lowest categories to nearly 2% in the highest-risk group, and the CHEST framework attaches approximate absolute risks (about 0.5%, 1.5%, 3%, and 6%) to guide whether early ambulation alone, intermittent pneumatic compression, or heparin-based prophylaxis is appropriate. The action driven by the score is therefore concrete: a low tally often justifies mechanical measures or ambulation only, while a high tally shifts the balance toward pharmacologic prophylaxis absent a competing bleeding risk.

Worked example

Consider a 68-year-old woman (age over 60 = 2) with an active colorectal malignancy (2) undergoing major open abdominal surgery lasting over 45 minutes (2), with a personal history of prior DVT (3) and expected confinement to bed more than 72 hours postoperatively (2). Her total is 11 points, placing her in the highest-risk tier. This supports pharmacologic prophylaxis with LMWH plus mechanical compression and, because this is abdominal-pelvic cancer surgery, extended-duration prophylaxis for about 4 weeks after discharge rather than in-hospital coverage only.

Limitations and safety notes

The score was derived and validated largely retrospectively from chart-abstracted risk factors, so scoring is sensitive to documentation completeness and inter-rater variation in how factors like "minor" versus "major" surgery are classified. Absolute VTE rates within each tier vary considerably by surgical subspecialty — plastic surgery, bariatric, and neurosurgical cohorts have reported different event rates at the same score — so a single universal cutoff can over- or under-treat particular populations. It quantifies thrombotic risk only and does not weigh bleeding risk, which must be assessed separately before committing to pharmacologic prophylaxis, and it is not validated for pediatric or purely medical patients.

Frequently asked questions

Which version of the Caprini score should I use — the 2005 or the 2013 model?

The most widely implemented version is the 2005 model, which underpins the Bahl validation and the CHEST guideline risk tiers; a later expanded version added factors and refined weighting. Use whichever your institutional protocol specifies and apply it consistently, since the tier cutoffs and prophylaxis mappings differ slightly between versions.

How does the Caprini score differ from the Padua Prediction Score?

Caprini is validated for surgical (non-orthopedic) inpatients and stratifies postoperative risk to guide perioperative prophylaxis, whereas the Padua score is designed for hospitalized medical patients. They are not interchangeable — using Padua for a surgical patient or Caprini for a medical admission applies each tool outside its validated population.

Does a high Caprini score automatically mean I should give heparin?

No. A high score identifies elevated thrombotic risk, but the decision to use pharmacologic prophylaxis also depends on bleeding risk, which the score does not measure. For high-risk patients with a high bleeding risk, guidelines favor mechanical prophylaxis with intermittent pneumatic compression until bleeding risk falls.

Why do two clinicians sometimes get different Caprini totals for the same patient?

Because scoring depends on how individual factors are captured and classified — for example whether a surgery is coded as minor or major, or whether a borderline history of thrombosis is counted. Standardizing definitions and using structured intake reduces this inter-rater variability.

References

  • Bahl V, Hu HM, Henke PK, Wakefield TW, Campbell DA, Caprini JA. A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg. 2010. PMID: 19779324.
  • Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, Samama CM. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012. PMID: 22315263.

Editorial review and citation methodology

Reviewed by the Quick Medical Calculator Editorial Team. Last reviewed: April 9, 2026. The review checks calculator inputs, intended population, interpretation, limitations, and source alignment.

  • Prefer original validation studies for scoring systems and prediction tools.
  • Use current specialty society guidance, transplant allocation policy, public health guidance, or regulator resources when they govern clinical use.
  • Include limitations and safety notes when a calculator is population-specific, context-dependent, or unsuitable as a standalone decision tool.

Related reviewed calculators